Co-administration of GnRH-agonist and hCG (double trigger) for final oocyte maturation increases the number of top-quality embryos in patients undergoing IVF/ICSI cycles.

MLA

Tu, Binbin, et al. “Co-Administration of GnRH-Agonist and HCG (Double Trigger) for Final Oocyte Maturation Increases the Number of Top-Quality Embryos in Patients Undergoing IVF/ICSI Cycles.” Journal of Ovarian Research, vol. 17, no. 1, July 2024, p. 137. EBSCOhost, https://doi.org/10.1186/s13048-024-01465-6.

APA

Tu, B., Zhang, H., Chen, L., Yang, R., Liu, P., Li, R., & Qiao, J. (2024). Co-administration of GnRH-agonist and hCG (double trigger) for final oocyte maturation increases the number of top-quality embryos in patients undergoing IVF/ICSI cycles. Journal of Ovarian Research, 17(1), 137. https://doi.org/10.1186/s13048-024-01465-6

Chicago

Tu, Binbin, Hua Zhang, Lixue Chen, Rui Yang, Ping Liu, Rong Li, and Jie Qiao. 2024. “Co-Administration of GnRH-Agonist and HCG (Double Trigger) for Final Oocyte Maturation Increases the Number of Top-Quality Embryos in Patients Undergoing IVF/ICSI Cycles.” Journal of Ovarian Research 17 (1): 137. doi:10.1186/s13048-024-01465-6.